Scolaris Content Display Scolaris Content Display

Intervenciones domiciliarias para el blanqueamiento de dientes en adultos

Esta versión no es la más reciente

Contraer todo Desplegar todo

Referencias

Referencias de los estudios incluidos en esta revisión

Barnes 1998 {published data only}

Barnes DM, Kihn PW, Romberg E, George D, DePaola L, Medina E. Clinical evaluation of a new 10% carbamide peroxide tooth‐whitening agent. Compendium of Continuing Education in Dentistry 1998;19(10):968‐72, 977‐8.

Brunton 2004 {published data only}

Brunton PA, Ellwood R, Davies R. A six‐month study of two self‐applied tooth whitening products containing carbamide peroxide. Operative Dentistry 2004;29(6):623‐6.

Cronin 2005 {published data only}

Cronin MJ, Charles CA, Zhao Q, Dembling WZ. Comparison of two over‐the‐counter tooth whitening products using a novel system. Compendium of Continuing Education in Dentistry 2005;26(2):140, 142, 144‐8.

Gerlach 2000 {published data only}

Gerlach RW, Gibb RD, Sagel PA. A randomized clinical trial comparing a novel 5.3% hydrogen peroxide whitening strip to 10%, 15%, and 20% carbamide peroxide tray‐based bleaching systems. Compendium of Continuing Education in Dentistry 2000;(29):S22‐8.

Gerlach 2001 {published data only}

Gerlach RW, Barker ML, Sagel PA. Comparative efficacy and tolerability of two direct‐to‐consumer tooth whitening systems. American Journal of Dentistry 2001;14(5):267‐72.

Gerlach 2002a {published data only}

Gerlach RW, Gibb RD, Sagel PA. Initial color change and color retention with a hydrogen peroxide bleaching strip. American Journal of Dentistry 2002;15(1):3‐7.

Gerlach 2002b {published data only}

Gerlach RW, Zhou X. Comparative clinical efficacy of two professional bleaching systems. Compendium of Continuing Education in Dentistry 2002;23(1A):35‐41.

Gerlach 2003 {published data only}

Gerlach RW, Barker ML. Randomized clinical trial comparing overnight use of two self‐directed peroxide tooth whiteners. American Journal of Dentistry 2003;16 Spec No:17B‐21B.

Gerlach 2004a {published data only}

Gerlach RW, Barker ML, Tucker HL. Clinical response of three whitening products having different peroxide delivery: comparison of tray, paint‐on gel, and dentifrice. Journal of Clinical Dentistry 2004;15(4):112‐7.

Gerlach 2004b {published data only}

Gerlach RW, Sagel PA. Vital bleaching with a thin peroxide gel: the safety and efficacy of a professional‐strength hydrogen peroxide whitening strip. Journal of the American Dental Association 2004;135(1):98‐100.

Karpinia 2002 {published data only}

Karpinia KA, Magnusson I, Sagel PA, Zhou X, Gerlach RW. Vital bleaching with two at‐home professional systems. American Journal of Dentistry 2002;15 Spec No:13A‐18A.

Karpinia 2003 {published data only}

Karpinia K, Magnusson I, Barker ML, Gerlach RW. Clinical comparison of two self‐directed bleaching systems. Journal of Prosthodontics 2003;12(4):242‐8.

Kihn 2000 {published data only}

Kihn PW, Barnes DM, Romberg E, Peterson K. A clinical evaluation of 10 percent vs. 15 percent carbamide peroxide tooth‐whitening agents. Journal of the American Dental Association 2000;131(10):1478‐84.

Kowitz 1994a {published data only}

Kowitz GM, Nathoo SA, Wong R. Comparative clinical evaluation of two professional tooth‐whitening products. Compendium Supplement 1994;(17):S635‐9.

Kowitz 1994b {published data only}

Kowitz GM, Nathoo SA, Rustogi KN, Chmielewski MB, Liang LJ, Wong R. Clinical comparison of Colgate Platinum Toothwhitening System and Rembrandt Gel Plus. Compendium Supplement 1994;(17):S646‐51.

Kugel 2000 {published data only}

Kugel G, Kastali S. Tooth‐whitening efficacy and safety: a randomized and controlled clinical trial. Compendium of Continuing Education in Dentistry. Supplement 2000;(29):S16‐21.

Li 2003 {published data only}

Li Y, Lee SS, Cartwright SL, Wilson AC. Comparison of clinical efficacy and safety of three professional at‐home tooth whitening systems. Compendium of Continuing Education in Dentistry 2003;24(5):357‐60, 362, 364.

Li 2004 {published data only}

Li Y, Lee SS, Cartwright S, Wilson AC, DeVizio W, Petrone M, et al. Comparative tooth whitening efficacy of 18% carbamide peroxide liquid whitening gel using three different regimens. Journal of Clinical Dentistry 2004;15(1):11‐6.

Matis 2000 {published data only}

Matis BA, Mousa HN, Cochran MA, Eckert GJ. Clinical evaluation of bleaching agents of different concentrations. Quintessence International 2000;31(5):303‐10.

Mokhlis 1999 {published data only}

Mokhlis JR. A three‐month clinical evaluation of 20‐percent carbamide peroxide and 7.5‐percent hydrogen peroxide whitening agents during daytime use [MSc thesis]. Indiana, USA: School of Dentistry, Indiana University, 1999.

Nathoo 1994 {published data only}

Nathoo SA, Chmielewski MB, Rustogi KN. Clinical evaluation of Colgate Platinum Professional Toothwhitening System and Rembrandt Lighten Bleaching Gel. Compendium Supplement 1994;(17):S640‐5.

Nathoo 2002 {published data only}

Nathoo S, Stewart B, Zhang YP, Chaknis P, Rustogi KN, DeVizio W, et al. Efficacy of a novel, nontray, paint‐on 18% carbamide peroxide whitening gel. Compendium of Continuing Education in Dentistry 2002;23(11 Suppl 1):26‐31.

Nathoo 2003 {published data only}

Nathoo S, Stewart B, Petrone ME, Chaknis P, Zhang YP, DeVizio W, et al. Comparative clinical investigation of the tooth whitening efficacy of two tooth whitening gels. Journal of Clinical Dentistry 2003;14(3):64‐9.

Panich 2001 {published data only}

Panich M. In vivo evaluation of 15‐percent carbamide peroxide and 5.5‐percent hydrogen peroxide whitening agents during daytime use [MSc thesis]. Indiana, USA: School of Dentistry, Indiana University, 2001.

Sielski 2003 {published data only}

Sielski C, Conforti N, Stewart B, Chaknis P, Petrone ME, DeVizio W, et al. A clinical investigation of the efficacy of a tooth‐whitening gel. Compendium of Continuing Education in Dentistry 2003;24(8):612‐4, 616‐8.

Referencias de los estudios excluidos de esta revisión

Auschill 2005 {published data only}

Auschill TM, Hellwig E, Schmidale S, Sculean A, Arweiler NB. Efficacy, side‐effects and patients' acceptance of different bleaching techniques (OTC, in‐office, at‐home). Operative Dentistry 2005;30(2):156‐63.

Browning 2004 {published data only}

Browning WD, Chan DC, Frazier KB, Callan RS, Blalock JS. Safety and efficacy of a nightguard bleaching agent containing sodium fluoride and potassium nitrate. Quintessence International 2004;35(9):693‐8.

Cibirka 1999 {published data only}

Cibirka RM, Myers M, Downey MC, Nelson SK, Browning WD, Hawkins IK, et al. Clinical study of tooth shade lightening from dentist‐supervised, patient‐applied treatment with two 10% carbamide peroxide gels. Journal of Esthetic Dentistry 1999;11(6):325‐31.

Collins 2004 {published data only}

Collins LZ, Maggio B, Gallagher A, York M, Schafer F. Safety evaluation of a novel whitening gel, containing 6% hydrogen peroxide and a commercially available whitening gel containing 18% carbamide peroxide in an exaggerated use clinical study. Journal of Dentistry 2004;32 Suppl 1:47‐50.

Ferrari 2004 {published data only}

Ferrari M, Kugel G, Cagidiaco MC, Barker ML, Gerlach RW. Clinical trial evaluating the peroxide concentration response of whitening strips over 28 days. American Journal of Dentistry 2004;17(4):291‐4.

Gambarini 2003 {published data only}

Gambarini G, Testarelli L, Dolci G. Clinical evaluation of a novel liquid tooth whitening gel. American Journal of Dentistry 2003;16(3):147‐51.

Gambarini 2004 {published data only}

Gambarini G, Testarelli L, De Luca M, Dolci G. Efficacy and safety assessment of a new liquid tooth whitening gel containing 5.9% hydrogen peroxide. American Journal of Dentistry 2004;17(2):75‐9.

Garcia 2004 {published data only}

Garcia‐Godoy F, Villalta P, Barker ML, Gerlach RW. Placebo‐controlled, 6‐week clinical trial on the safety and efficacy of a low‐gel, 14% hydrogen‐peroxide whitening strip. Compendium of Continuing Education in Dentistry 2004;25(8 Suppl 2):21‐6.

Gegauff 1993 {published data only}

Gegauff AG, Rosenstiel SF, Langhout KJ, Johnston WM. Evaluating tooth color change from carbamide peroxide gel. Journal of the American Dental Assocation 1993;124(6):65‐72.

Gerlach 2002c {published data only}

Gerlach RW, Sagel PA, Jeffers ME, Zhou X. Effect of peroxide concentration and brushing on whitening clinical response. Compendium of Continuing Education in Dentistry 2002;23(1A):16‐21.

Gerlach 2002d {published data only}

Gerlach RW, Barker ML, Sagel PA. Objective and subjective whitening response of two self‐directed bleaching systems. American Journal of Dentistry 2002;15 Spec No:7A‐12A.

Gerlach 2002e {published data only}

Gerlach RW, Zhou X, McClanahan SF. Comparative response of whitening strips to a low peroxide and potassium nitrate bleaching gel. American Journal of Dentistry 2002;15 Spec No:19A‐23A.

Gerlach 2003b {published data only}

Gerlach RW, Barker ML. Clinical response of three direct‐to‐consumer whitening products: strips, paint‐on gel, and dentifrice. Compendium of Continuing Education in Dentistry 2003;24(6):458, 461‐4, 466.

Gerlach 2004c {published data only}

Gerlach RW, Zhou X. Clinical trial comparing two daytime hydrogen‐peroxide professional vital‐bleaching systems. Compendium of Continuing Education in Dentistry 2004;25(8 Suppl 2):33‐40.

Godder 1994 {published data only}

Godder B, Kaim JM, Scherer W, Bruck I, Hertz BM. Evaluation of two at‐home bleaching systems. Journal of Clinical Dentistry 1994;5:86‐8.

Howard 1992 {published data only}

Howard WR. Patient‐applied tooth whiteners. Journal of the American Dental Association 1992;123(2):57‐60.

Ishikawa 2004 {published data only}

Ishikawa‐Nagai S, Terui T, Ishibashi K, Weber HP, Ferguson M. Comparison of effectiveness of two 10% carbamide peroxide tooth‐bleaching systems using spectrophotometric measurements. Journal of Esthetic and Restorative Dentistry 2004;16(6):368‐76.

Karpinia 2003b {published data only}

Karpinia KA, Magnusson I, Barker ML, Gerlach RW. Placebo‐controlled clinical trial of a 19% sodium percarbonate whitening film: initial and sustained whitening. American Journal of Dentistry 2003;16 Spec No:12B‐16B.

Kozlovsky 1996 {published data only}

Kozlovsky A, Sintov A, Artzi Z, Tal H. Clinical efficacy of a degradable film‐forming product containing carbamide peroxide to reduce tooth discolouration. Oral Health 1996;86(3):47‐9, 53‐6.

Leonard 2001 {published data only}

Leonard RH, Bentley C, Eagle JC, Garland GE, Knight MC, Phillips C. Nightguard vital bleaching: a long‐term study on efficacy, shade retention. side effects, and patients' perceptions. Journal of Esthetic and Restorative Dentistry 2001;13(6):357‐69.

Matis 1998 {published data only}

Matis BA, Cochran MA, Eckert G, Carlson TJ. The efficacy and safety of a 10% carbamide peroxide bleaching gel. Quintessence International 1998;29(9):555‐63.

Matis 2002 {published data only}

Matis BA, Hamdan YS, Cochran MA, Eckert GJ. A clinical evaluation of a bleaching agent used with and without reservoirs. Operative Dentistry 2002;27(1):5‐11.

Mokhlis 2000 {published data only}

Mokhlis GR, Matis BA, Cochran MA, Eckert GJ. A clinical evaluation of carbamide peroxide and hydrogen peroxide whitening agents during daytime use. Journal of the American Dental Association 2000;131(9):1269‐77.

Myers 2003 {published data only}

Myers MI, Browning WD, Downey MC, Hackman ST. Clinical evaluation of a 3% hydrogen peroxide tooth‐whitening gel. Journal of Esthetic and Restorative Dentistry 2003;15(1):50‐5, 56.

Ouellett 1992 {published data only}

Ouellet D, Los S, Case H, Healy R. Double‐blind whitening Night‐Guard study using ten percent carbamide peroxide. Journal of Esthetic Dentistry 1992;4(3):79‐83.

Reinhardt 1993 {published data only}

Reinhardt JW, Eivins SE, Swift EJ, Denehy GE. A clinical study of nightguard vital bleaching. Quintessence International 1993;24(6):379‐84.

Rosenstiel 1996 {published data only}

Rosenstiel SF, Gegauff AG, Johnston WM. Randomized clinical trial of the efficacy and safety of a home bleaching procedure. Quintessence International 1996;27(6):413‐24.

Russell 1996 {published data only}

Russell CM, Dickinson GL, Johnson MH, Curtis JW, Downey MC, Haywood VB, et al. Dentist‐supervised home bleaching with ten percent carbamide peroxide gel: a six‐month study. Journal of Esthetic Dentistry 1996;8(4):177‐82.

Sagel 2002 {published data only}

Sagel PA, Jeffers ME, Gibb RD, Gerlach RW. Overview of a professional tooth‐whitening system containing 6.5% hydrogen peroxide whitening strips. Compendium of Continuing Education in Dentistry 2002;23(1A):9‐15.

Simon 1993 {published data only}

Simon JF, Allen H, Woodson RG, Eilers AS. Efficacy of vital home bleaching. Journal of the California Dental Association 1993;21(1):72‐5.

Small 1994 {published data only}

Small BW. Bleaching with 10 percent carbamide peroxide: an 18‐month study. General Dentistry 1994;42(2):142‐6.

Swift 1997 {published data only}

Swift EJ, May KN, Wilder AD, Heymann HO, Wilder RS, Bayne SC. Six‐month clinical evaluation of a tooth whitening system using an innovative experimental design. Journal of Esthetic Dentistry 1997;9(5):265‐74.

Swift 1999 {published data only}

Swift EJ, May KN, Wilder AD, Heymann HO, Bayne SC. Two‐year clinical evaluation of tooth whitening using an at‐home bleaching system. Journal of Esthetic Dentistry 1999;11(1):36‐42.

Swift 2004 {published data only}

Swift EJ, Miguez PA, Barker ML, Gerlach RW. Three‐week clinical trial of a 14% hydrogen‐peroxide, strip‐based bleaching system. Compendium of Continuing Education in Dentistry 2004;25(8 Suppl 2):27‐32.

Tam 1999 {published data only}

Tam L. Clinical trial of three 10% carbamide peroxide bleaching products. Journal of the Canadian Dental Association 1999;65(4):201‐5.

Referencias adicionales

ADA 2004

American Dental Association. Dentist dispensed home‐used tooth bleaching products. www.ada.org/prof/resources/positions/standards/guide_home_bleach.pdf(accessed September 2005).

ADA 2005a

American Dental Association. ADA statement on the safety and effectiveness of tooth whitening products. www.ada.org/prof/resources/positions/statements/whiten2.asp(accessed September 2005).

ADA 2005b

American Dental Association. Clinical trials protocol. www.ada.org/prof/resources/positions/standards/guide_clinical_trial.pdf(accessed September 2005).

ADA 2006

American Dental Association. Complete list of ADA seal products. www.ada.org/ada/seal/index.asp(accessed March 2006).

BBC 2005

British Broadcasting Corporation (BBC News). Dentists: Legalise tooth whitening. http://news.bbc.co.uk/1/hi/health/411632.stm(accessed September 2005).

BDA 2005

British Dental Association. Whitening or bleaching?. http://news.bbc.co.uk/1/hi/health/784072.stm(accessed September 2005).

CIE 1978

Commission Internationale de L'Eclairage. Recommendations on uniform colour spaces, colour difference equations and psychometric colour terms. Supplement Number 2, Publication Number 15. Bureau Central de La CIE1978.

Cooley 1974

Cooley R. Dilema of the discolored teeth due to tetracycline staining. Current Opinion in Dentistry 1974;5:587‐92.

Cooper 1992

Cooper JS, Bokmeyer TJ, Bowles WH. Penetration of the pulp chamber by carbamide peroxide bleaching agents. Journal of Endodontics 1992;18(7):315‐7.

Darnell 1990

Darnell DH, Moore WC. Vital tooth bleaching: the White and Brite technique. Compendium 1990;11(2):86, 88‐90, 92‐4.

EC 2005

European Commission on Consumer Products. Scientific committee on consumer products opinion on hydrogen perioxide in tooth whitening. http://ec.europa.eu/comm/health/ph_risk/committees/04_sccp/sccp_opinions_en.htm(accessed December 2005).

Egger 1997

Egger M, Smith GD, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315:629‐34.

Gonzalez‐Ochoa 2002

Gonzalez‐Ochoa J. Histological changes to dental pulp after vital bleaching with 10% carbamide peroxide. Indiana, USA: School of Dentistry, Indiana University2002.

Haywood 1989

Haywood VB, Heymann HO. Nightguard vital bleaching. Quintessence International 1989;20(3):173‐6.

Haywood 1994

Haywood VB, Leonard RH, Nelson CF, Brunson WD. Effectiveness, side effects and long‐term status of nightguard vital bleaching. Journal of the American Dental Association 1994;125(9):1219‐26.

Higgins 2005

Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. www.cochrane.dk/cochrane/handbook/hbook.htm (accessed 25th September 2005).

Leonard 1998

Leonard RH, Sharma A, Haywood VB. Use of different concentrations of carbamide peroxide for bleaching teeth: an in vitro study. Quintessence International 1998;29(8):503‐7.

Moher 2003

Moher D, Schulz KF, Altman DG, CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel‐group randomised trials. Clinical Oral Investigations 2003;7(1):2‐7.

Nathanson 1987

Nathanson D, Parra C. Bleaching vital teeth: a review and clinical study. Compendium 1987;8(7):490‐2, 494, 496‐7.

NHS 2004

National Health Service (NHS Dentistry). Delivering change. www.dh.gov.uk/assetRoot/04/08/59/75/04085975.pdf(accessed September 2005).

Rustogi 1994

Rustogi KN, Curtis J. Development of a quantitative measurement to assess the whitening effects of two different oxygenating agents on teeth in vivo. Compendium Supplement 1994;(17):S631‐4.

Sarrett 2002

Sarrett DC. Tooth whitening today. Journal of the American Dental Association 2002;133(11):1535‐8.

Wainwright 1950

Wainwright WW, Lemoine FA. Rapid diffuse penetration of intact enamel and dentin by carbon 14‐labeled urea. Journal of the American Dental Association 1950;41(2):135‐45.

Yarborough 1991

Yarborough DK. The safety and efficacy of tooth bleaching: a review of the literature 1988‐1990. Compendium 1991;12(3):191‐6.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Barnes 1998

Methods

Stratified, matched‐pair, clinical study. Change assessed at baseline, 2 weeks, 3 months, and 6 months from baseline.

Participants

61 adult subjects. Age = 18‐65 years. Groups were matched by age, sex, and gingival health. Maxillary anterior teeth shade A3 or darker.

Interventions

Group 1: placebo with 0% CP, gel applied in a tray. Group 2: NUPRO Gold, with 10% CP, gel applied in a tray.

Outcomes

10% CP had statistically significant improvement when compared to 0% (P < 0.01).

Notes

Vita Shade Guide. Supported by Dentsply Preventive Care. Each member of a pair was 'allocated' to a group. It is not clear at which point the examiner knew which subjects were in each group.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Brunton 2004

Methods

Randomised, controlled clinical study. Change assessed at baseline and at 2 weeks and 6 months from baseline.

Participants

95 subjects (47 group 1, 48 group 2), males and females, ranging in age from 18‐70 years. Minimum Vita Shade A3 on at least 1 upper central incisor.

Interventions

Group 1: Colgate Simply White, 18% CP, paint‐on gel. Group 2: Colgate Simply White, 16.4% CP, paint‐on gel.

Outcomes

No significant difference between 18% CP and 16.4% CP in teeth whitening. Significant reduction in gingival scores P < 0.001. Transient tooth and gingival sensitivity reported by 15% of participants.

Notes

Vita Shade Guide. Supported by Colgate Palmolive.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Cronin 2005

Methods

Stratified, randomised, parallel group, clinical study. Follow up: 2 weeks.

Participants

59 adult subjects, age ranged from 20‐60 years old. 83% of participants were female and 90% were white. Vitapan shade A2 or more on at least 2 maxillary incisors. Group 1: n = 29, ages 20‐60, 86% female, 90% white; group 2: n = 30, ages 28‐57, 80% female, 90% white (3 smokers, 2 in group 1).

Interventions

Group 1: used 6% HP, applied as gel in a strip. Group 2: used 18% CP. Brush‐applied liquid gel.

Outcomes

6% HP gel in a strip had statistically significant improvement in whitening compared with 18% CP gel paint‐on. (Vita Shade ‐ P = 0.005; Shade Vision ‐ P = 0.001).

Notes

1) Vita Shade Guide and 2) Chroma (Shade Vision). 1 subject claimed increased sensitivity when using HP. Supported by Pfizer.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Gerlach 2000

Methods

Stratified, randomised, examiner‐blind, 4‐group clinical study. Follow up: 2 weeks. Assessment was using digital image and computer analysis.

Participants

Respectively n = 10, ages 24‐57, 90% female, 100% white; n = 10, ages 29‐52, 90% female, 90% white; n = 11, ages 25‐47, 82% female, 91% white; and n = 5, ages 31‐51, 60% female, 100% white in the 4 groups. Only 1 participant (group 4) smoked.

Interventions

Group 1: Crest Whitestrips, gel in strips, 5.3% HP applied 2x30 min daily. Group 2: Opalescence, 10% CP, gel applied in a tray 2 hr daily. Group 3: Opalescence, 15% CP + F, gel applied in a tray 2 hr daily. Group 4: Opalescence, 20% CP + F, gel applied in a tray 2 hr daily.

Outcomes

Group 4 showed significantly greater composite colour change when compared with other groups (P = 0.005, P < 0.05, P < 0.01 versus groups 1, 2, and 3). Groups 2, 3, and 4 transient tooth sensitivity (0‐60%) and minor oral irritation (27‐30%), more common in group 4.

Notes

Chroma Meter. Supported by Procter and Gamble.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Gerlach 2001

Methods

Randomised, examiner‐blind, parallel group clinical trial. Follow up: 2 weeks. Assessment was using digital image and computer analysis.

Participants

Group 1: n = 10, ages 25‐48, 70% female, 90% white; group 2: n = 10, ages 26‐56, 70% female, 90% white (2 smokers). 3 subjects lost from group 2.

Interventions

Group 1: Crest Whitestrips, 6.0%, HP, gel in strips, 30 min before brushing daily. Group 2: Rembrandt Superior Plus Bleaching System, 10%, CP, gel in tray, 20‐30 min after brushing daily then whitening rinse.

Outcomes

Combined colour change was significantly greater for group 1 than group 2 (P < 0.001). Tooth sensitivity reported in 40% of group 1 and 10% of group 2. Oral irritation was reported in 70% of group 2.

Notes

Chroma Meter. Supported by Procter and Gamble.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Gerlach 2002a

Methods

Stratified, randomised, placebo‐controlled, double‐blind clinical trial. Follow up: 2 weeks and 6 months with assessment by digital image analysis.

Participants

Group 1: n = 28, ages 19‐61, 75% female, 89% white; group 2: n = 29, ages 18‐71, 79% female, 83% white. 4 smokers in each group. 5 subjects were lost from group 1 and 3 from group 2.

Interventions

Group 1: used Crest Whitestrips, with 5.3% HP gel 30 min 2x daily. Group 2: Placebo Strip, 0% HP gel 30 min 2x daily. Both mandibular and maxillary teeth were treated.

Outcomes

Combined colour change was significantly greater for group 1 than group 2 (P < 0.001). Tooth sensitivity reported in 10% of group 1 and 3% of group 2. Oral irritation was reported in 3 participants, 2 in group 1 and the other in 2.

Notes

Chroma Meter. Supported by Procter and Gamble.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Gerlach 2002b

Methods

Stratified, randomised, examiner‐blind, 2‐group clinical study. Follow up: 2 weeks with assessment by digital image analysis.

Participants

Group 1: n = 10, ages 22‐49, 50% female, 80% white; group 2: n = 10, ages 24‐59, 40% female, 90% white. 10% were smokers.

Interventions

Group 1: used Crest Professional Whitestrips, with 6.5% HP, gel 2x30 min daily. Group 2: used Nite White Excel 2, with 10% CP, gel applied in a tray 1x2 hr daily.

Outcomes

Combined colour change was significantly greater for group 1 than group 2 (P < 0.05). Tooth sensitivity reported in 20% of group 1 and 10% of group 2. Gingival irritation was reported in 30% of participants in group 1, only.

Notes

Chroma Meter (ShadeEyeEx). Supported by Procter and Gamble.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Gerlach 2003

Methods

Stratified, randomised clinical study. Follow up: 2 weeks with assessment by digital image analysis.

Participants

57 healthy adults with 4 maxillary teeth Vitapan shade A2 or darker. Mean age was 40.3, 56% were female, and 14% were smokers. 30 participants were in group 1 (1 drop out) and 27 were in group 2.

Interventions

Group 1: used Crest Night Effects 19% SP and group 2: used Colgate Simply White Night paint‐on gel containing 8.7% HP. Each was applied at night after brushing and left in place until morning.

Outcomes

Combined colour change was significantly greater for group 1 than group 2 (P < 0.001). 1 participant from each group reported tooth sensitivity and 1 in group 1 reported mild oral irritation.

Notes

Chroma Meter. Supported by Procter and Gamble.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Gerlach 2004a

Methods

Stratified, randomised, parallel group. Follow up: 2 weeks with assessment by digital image analysis.

Participants

Respectively n = 14, ages 18‐69, 71% female; n = 14, ages 18‐56, 50% female; n = 15, ages 19‐70 in the 3 groups. There were 2 smokers in each of groups 1 and 3. 1 participant was lost to follow up in group 2.

Interventions

Group 1: used dentifrice, with 1% HP and manganese gluconate activator for 2 min 2x daily both arches. Group 2: used a paint‐on gel with 18% CP 2x daily both arches, and group 3: bleaching paste containing 5% CP in custom tray overnight.

Outcomes

Combined colour change did not differ significantly between groups 1 and 2 but was significantly greater for group 3 compared to group 1 (P < 0.005) and group 2 (P < 0.01). Tooth sensitivity was reported in 33% of group 3 and oral irritation in 21% of group 1 and 33% of group 3. There were no reports of either in group 2.

Notes

Chroma Meter. Supported by Procter and Gamble.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Gerlach 2004b

Methods

Randomised, double‐blind, clinical study. Follow up: 1 and 2 weeks.

Participants

38 healthy adults aged 18‐50, 61% female. Does not indicate how many in each group but 1 lost from group 1.

Interventions

Group 1: used Crest Whitestrips Supreme, with 14% HP 30 min x2 daily; group 2: used Crest Whitestrips, with 6% HP 30 min x2 daily.

Outcomes

Combined colour change was significantly greater for group 1 than group 2 (P < 0.005). 42% of group 1 and 26% of group 2 reported sensitivity and 11% of each reported oral irritation.

Notes

Chroma Meter. Supported by Procter and Gamble. Short report no details.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Karpinia 2002

Methods

Stratified, randomised clinical trial. Follow up at 1, 2, and 3 weeks. Assessment was using digital images.

Participants

Group 1: n = 35, ages 18‐65, 74% female, 87% white, 11% smokers; group 2: n = 34, ages 19‐57, 74% female, 82% white, 8% smokers. Minimum 4 maxillary anterior teeth shade A2 or darker. 3 subjects lost from group 2.

Interventions

Stain removal for all. Group 1: used Professional Crest Whitestrips with 6.5% HP gel in a strip 30 min 2x daily; group 2: used Nite White Excel 2, with a 10% CP gel in a tray 2 hr per day.

Outcomes

Combined colour change was significantly greater for group 1 than group 2 (P < 0.001). 26% of group 1 and 15% of group 2 reported sensitivity and 14% of group 1 and 24% of group 2 reported oral irritation.

Notes

Chroma Meter. Supported by Procter and Gamble.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Karpinia 2003

Methods

Stratified, randomised clinical trial. Treatment for 14 days with assessment, using digital images, at baseline, 1, and 2 weeks.

Participants

Group 1: n = 29, ages 19‐52, 72% female, 97% white, 24% smokers; group 2: n = 28, ages 18‐60, 86% female, 93% white, 11% smokers.

Interventions

Group 1: used Crest Whitening strip, with 6% HP 2x 30 min daily. Group 2: used tray based whitening/dentifrice/rinse, with a 10% CP 2x 20‐30 min daily.

Outcomes

Combined colour change was significantly greater for group 1 than group 2 (P < 0.001). 17% of group 1 and 11% of group 2 reported sensitivity and 31% of group 1 and 50% of group 2 reported oral irritation.

Notes

Chroma Meter. Supported by Procter and Gamble.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Kihn 2000

Methods

Stratified, randomised clinical trial. Assessed at baseline, 1, and 2 weeks plus 2 weeks post‐treatment.

Participants

57 adults aged 18‐65 with anterior maxillary teeth A3 or darker, paired by age and sex.

Interventions

Intial professional prophylaxis for all participants. Group 1: NUPRO Gold, 10% CP. Gel applied in a tray. Group 2: NUPRO Gold, 15% CP. Both groups instructed to wear tray 4 hr‐o/n.

Outcomes

Colour shade change was significantly greater for group 2 than group 1 (P < 0.05). Sensitivity, on a 20‐point scale, was reported as 2.78 ± 2.44 for group 1 and 4.19 ± 4.58 for group 2 (P > 0.05).

Notes

Vita Shade Guide. Sponsored by Dentsply Caulk.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Kowitz 1994a

Methods

Blinded, parallel clinical study. Products used for 14 days, assessment by reflectance spectroscopy at baseline, 1, and 2 weeks.

Participants

50 healthy adults with teeth assessed as A3 or darker on the Vita Shade Guide.

Interventions

Group 1: Colgate Platinum Pro, 10% CP, gel applied in tray, 1 hr x2 daily. Group 2: Rembrandt Lighten, 10% CP, gel applied in tray, 1 hr x2 daily.

Outcomes

Combined colour change was significantly greater for group 1 than group 2 (P < 0.001). No adverse reactions were noted.

Notes

Chroma Meter. Supported by Colgate Palmolive.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Kowitz 1994b

Methods

Single‐blind, randomised, parallel, clinical study. Colour measurements taken on mid‐facial aspects of upper central incisors. Treatment continued for 2 weeks with assessment at start and 1 and 2 weeks.

Participants

75 healthy adults with teeth assessed as A3 or darker on the Vita Shade Guide aged 23‐68 including 30 males, 40 females, and 5 not detailed.

Interventions

Initial professional prophylaxis for all participants. Group 1: Colgate Platinum Pro, 10% CP, gel applied in a tray. Group 2: Rembrandt Gel Plus, 10% CP, applied in a tray. Group 3: placebo, 0% CP, gel applied in tray. All treatments 1 hr x2 daily for 14 days.

Outcomes

Combined colour change was significantly greater for group 1 than group 2 (P < 0.001) and for group 1 than group 3 (P < 0.001). Authors did not present significance of increased colour change between group 2 and 3. Details of sensitivity and irritation were not presented.

Notes

Chroma Meter. Supported by Colgate Palmolive.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Kugel 2000

Methods

Randomised, placebo‐controlled trial. Up to 6 maxillary incisors or canines assessed at baseline and 2‐week follow up.

Participants

70 adults, 3 or more shade A2 or darker maxillary teeth. Group 1: n = 35, ages 18‐66, 57% female, 77% white; group 2: n = 35, ages 22‐56, 51% female, 86% white. 2 in each group lost to follow up.

Interventions

Group 1: Polyethylene film with gel containing 5.3% HP gel 2x 30 min daily; group 2: Polyethylene film with gel without HP gel 2x 30 min daily.

Outcomes

Colour shade change was significantly greater for group 1 than group 2 (P < 0.001). No exacerbation of baseline pathology was noted and plaque and gingivitis scores did not differ significantly between groups though both experienced significant reductions in these measures due to inclusion in the trial (P < 0.001).

Notes

Vita Shade Guide. Supported by Procter and Gamble.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Li 2003

Methods

A 3‐group, randomised, parallel, clinical study. Whiteness was assessed by shade comparison and by Chroma Meter at baseline and at 3, 7, 14, and 21 (18 group 1) days.

Participants

90 adults with 4 or more shade A3 or darker (Vitapan Classical) maxillary incisors: respectively, n = 30, ages 25‐67, 63% female; n = 30, ages 26‐64, 70% female, and n = 30, ages 25‐59, 67% female. 1, 3, and 4 subjects were lost from the study.

Interventions

Initial professional prophylaxis for all participants. Group 1: Crest Professional Whitestrips, 6.5% HP gel, 2x 30 min daily; group 2: Day White 2 with 7.5% HP gel applied in a tray, 2x 30 min daily; group 3: Nite White Excel Mint with 16% CP equivalent gel applied in a tray, o/n.

Outcomes

Shades were assessed by 2 examiners independently. The average shade for group 3 was significantly less than the other 2 groups (P < 0.5) which were comparable with each other. Chroma Meter values agreed with this result. Self reported gingival irritation varied between 40.7 and 62.3% through the period for group 2, 7%‐23% for group 1, and 0 to 12% for group 3. Sensitivity was reported as 12‐19%, 25‐41%, and 8‐24% respectively for the 3 groups.

Notes

Vita Shade Guide and Chroma Meter. Supported by Discus Dental (manufacturer of Day White and Nite White).

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Li 2004

Methods

Stratified, randomised, 3‐group, clinical trial. Clinical assessment at baseline and 1, 2, and 3 weeks.

Participants

120 adults with all maxillary anterior teeth present and classifiable as shade A3 or darker (Vitapan Classical). 3 groups: respectively n = 40, ages 18‐65, 69% female; n = 40, ages 20‐65, 71% female; n = 40, ages 19‐65, 62% female. 16 drop outs not included in these values.

Interventions

All groups used paint‐on 18% CP gel. Group 1: 2x daily, no air drying, and no eating/drinking for 15 min; group 2: 3x daily, 30 sec air‐drying, 30 min no eating/drinking; group 3: 4x daily, 30 sec air‐drying, 30 min no eating/drinking.

Outcomes

Groups 2 and 3 showed significantly higher mean shade change from baseline than group 1 (P < 0.05). The values for groups 2 and 3 did not differ significantly from each other. 1 participant only (group 3) reported mild sensitivity at 7‐day examination but not at further time points. No significant differences occurred in changes in GI scores.

Notes

Vita Shade Guide. Supported by Colgate Palmolive.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Matis 2000

Methods

Split‐mouth design, double blind, randomised trial with treatment for 14 days. Colorimetric assessments made at baseline, 3 days, and 1, 2, 3, and 6 weeks.

Participants

25 adults with complete maxillary anterior dentition not lighter than B54 or darker than B85 (Trubyte Shade Guide from Dentsply) or discoloured by tetracycline staining. 8 males and 17 females aged 26‐73 were randomised 12 to group 1 and 13 to group 2. All completed the study.

Interventions

Initial professional prophylaxis for all participants. Group 1: 10% CP, gel applied to right anterior maxillary teeth in a custom mouthguard o/n for up to 14 days and group 2: same but with 15% CP. Both asked to maintain good oral hygiene.

Outcomes

Colour shade change was significantly greater for group 2 than group 1 at 3 weeks (P < 0.001) but the difference was not significant at 6 weeks. Slightly higher sensitivity was noted with group 2 but this difference was not significant.

Notes

Chroma Meter. Supported by Ultradent Products.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Mokhlis 1999

Methods

Twin strand study. Double‐blind, split‐mouth design. Teeth assessed by visually live and from photographs and Colorimetrically with computer processing at baseline and 1, 2, 3, 6, and 12 weeks.

Participants

25 adult non‐smokers with complete maxillary anterior dentition not lighter than B54 or darker than B85 (Trubyte Shade Guide from Dentsply) or discoloured by tetracycline staining, aged 28‐80. The 14 females and 11 males were separated into those with teeth B95 or darker and those with teeth judged B94 or paler.

Interventions

Initial professional prophylaxis for all participants. Absolutely unclear. Appears both blocks based on initial shade were each asked to use both treatments on 1 side of their maxilla with placement being assigned by some randomisation process. The 2 treatments were 20% CP and 7.5% HP applied in a custom tray for 2 1 hr periods, 1 in the morning and 1 at night.

Outcomes

For the purpose of analysis, all groups were combined. No significant differences were seen between teeth whitened with either reagent. Sensitivity was not reported in terms of numbers of repartees but no significant difference between products was noted.

Notes

Minolta Chroma Meter 321 and Vita Shade Guide. Supported by Ultradent and Discus Dental Inc.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Nathoo 1994

Methods

Stratified blinded, randomised, parallel clinical study. Change in tooth colour measured by reflectance spectroscopy (Minolta) at baseline and 1 and 2 weeks.

Participants

40 adults with tooth discolouration of Vita Shade A3 or darker. No other details given.

Interventions

Product was used 30 min morning and 30 min evening for 14 days. Group 1: Colgate Platinum Pro 10% CP gel; group 2: Rembrandt Lighten, 10% CP gel.

Outcomes

Colour shade change was significantly greater for group 1 than group 2 (P < 0.001). Statistical significance only quantified for 1 week, though absolute difference was greater after 2 weeks.

Notes

Chroma Meter. Sponsored by Colgate Palmolive.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Low risk

A ‐ Adequate

Nathoo 2002

Methods

Stratified, randomised, parallel group, clinical study. Vita Shade scores assessed at baseline and after 2 and 3 weeks by closest match of facial surface of teeth.

Participants

80 adults with full set of maxillary anterior teeth Vita Shade A3 or darker. Not counting drop outs (3), the age range was 18‐58 and 60% of participants were female.

Interventions

Participants brushed teeth, applied gel with brush, air dried 30 sec, and refrain from food/drink 30 min. Group 1: Colgate Simply White Clear Whitening Gel, 18% CP, paint‐on gel; group 2: placebo, 0% CP, paint‐on gel.

Outcomes

Colour shade change was significantly greater for group 1 than group 2 (P < 0.05). No mention was made of irritation or sensitivity.

Notes

Vita Shade Guide. Sponsored by Colgate Palmolive.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Nathoo 2003

Methods

Stratified, randomised, parallel group, clinical study. Vita Shade scores assessed at baseline and at 2 and 3 weeks by closest match of facial surface of teeth.

Participants

59 adults with full set of maxillary anterior teeth Vita Shade A3 or darker aged 18‐70.

Interventions

Before retiring, participants brushed teeth, applied gel with brush tooth by tooth, and refrain from food/drink 15 min. Group 1: Colgate Simply White Clear Whitening 25% CP paint‐on gel; group 2: Colgate Simply White Night Clear Whitening 8.7% HP paint‐on gel.

Outcomes

No significant differences in colour shade were seen between teeth whitened with either product (P > 0.05).

Notes

Vita Shade Guide. Sponsored by Colgate Palmolive.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Panich 2001

Methods

Split‐mouth design with 1 product on right side and other on left, randomly assigned. Assessment using shade guide (Trubyte) and Chroma Meter at baseline, 3 days, and 1, 2, 3, and 6 weeks.
Follow up: 2 and 3 weeks and 3 months.

Participants

25 adult non‐smokers with complete maxillary anterior dentition not lighter than B54 or darker than B85 (Trubyte Shade Guide from Dentsply) or discoloured by tetracycline staining, ages 31‐73, 56% female.

Interventions

Each participant used both reagents by applying 1 to each side of a custom tray and wearing for 2x 30 min daily. Product 1: Day White 5.5% HP, in gel form; product 2: Opalescence F 15% CP, in gel form.

Outcomes

Combined colour change did not significantly differ between products when assessed by Chroma Meter at 6 weeks (P = 0.94) or by shade comparison (P = 0.33). Tooth and gum sensitivity did not differ significantly between mouth sides.

Notes

Chroma Meter. Supported by Ultradent and Discus Dental Inc.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

Sielski 2003

Methods

Stratified, randomised, parallel group, clinical study. Tooth shade assessments at baseline and at 2 and 3 weeks. Group 1 was additionally assessed at 6 months.

Participants

75 adults with full set of maxillary anterior teeth with minimum Vita Shade A3. Group 1 ages 19‐70, 63% female and group 2 ages 18‐68, 70% female.

Interventions

Group 1: Colgate Simply White Clear Whitening Gel. 25% CP paint‐on gel. Participants brushed teeth, applied gel with brush, air dried 30 sec, and refrain from food/drink 30 min. Group 2: Colgate standard toothpaste, with 0% peroxide paste.

Outcomes

Colour shade change was significantly greater for group 1 than group 2 (P < 0.05). No mention was made of irritation or sensitivity.

Notes

Vita Shade Guide. Supported by Colgate Palmolive.

Risk of bias

Bias

Authors' judgement

Support for judgement

Allocation concealment?

Unclear risk

B ‐ Unclear

CP = Carbamide peroxide; HP = Hydrogen peroxide; SP = Sodium percarbonate.

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Auschill 2005

No data were reported on whitening of teeth.

Browning 2004

No mean values were reported (only the median and per cent improvement).

Cibirka 1999

No mean values were reported (only the median).

Collins 2004

Evaluation of soft tissues and no data were reported on whitening of teeth.

Ferrari 2004

No data on Delta E were reported.

Gambarini 2003

Before and after design; no control group.

Gambarini 2004

Only percentage differences in shade guides were reported.

Garcia 2004

Data were reported after 3 and 6 weeks post‐treatment.

Gegauff 1993

Data on Delta E were not reported.

Gerlach 2002c

Measurements were carried out at 7 days in one group and 14 days in the second group.

Gerlach 2002d

Only percentages of subjects with improvement in colour were reported.

Gerlach 2002e

Duration of follow up was 1 week post‐treatment.

Gerlach 2003b

Data were reported after 3 weeks post‐treatment.

Gerlach 2004c

Data were reported after 22 days post‐treatment and not after 2 weeks, which was the time point used in this review.

Godder 1994

Only data on individual shade scores per subject were reported.

Howard 1992

No relevant data were presented on the 2‐week follow up. Evaluation of tooth colour was carried out using a guide with 24 shade tabs while the Vita Shade Guide in all included studies has 16 shade tabs.

Ishikawa 2004

Data were presented separately for specific teeth; hence, incomparable with the other included studies.

Karpinia 2003b

Data were not reported for differences in shade guides between experimental and control groups.

Kozlovsky 1996

Data on Delta E could not be estimated from the reported graphs.

Leonard 2001

No mean values were reported (median shade change only).

Matis 1998

Data were reported after 4 and 22 weeks of follow up but not after 2 weeks.

Matis 2002

Study evaluated the effect of adding reservoirs to trays.

Mokhlis 2000

A duplicate study of an included master thesis.

Myers 2003

No mean values were reported (median shade change).

Ouellett 1992

Data on Delta E were not reported.

Reinhardt 1993

Follow up was overnight and 3 hours after bleaching.

Rosenstiel 1996

Data could not be estimated from the reported figures.

Russell 1996

No means or standard deviations were reported.

Sagel 2002

Insufficient data published.

Simon 1993

A densitometer was used to assess the change in colour; not comparable with the other included studies.

Small 1994

No relevant data were reported for the purposes of this review.

Swift 1997

No means or standard deviations were reported.

Swift 1999

Only frequencies of individuals by each shade code were reported.

Swift 2004

Only 3‐week results were reported.

Tam 1999

Not a randomised controlled trial and no relevant data were reported.

Data and analyses

Open in table viewer
Comparison 1. Whitening product versus placebo/no treatment ‐ Vita Shade

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Gel in tray versus placebo (change in shade baseline to 2 weeks) Show forest plot

1

50

Mean Difference (IV, Random, 95% CI)

‐6.29 [‐7.82, ‐4.76]

Analysis 1.1

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 1 Gel in tray versus placebo (change in shade baseline to 2 weeks).

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 1 Gel in tray versus placebo (change in shade baseline to 2 weeks).

2 Paint‐on film versus placebo/no treatment (shade change baseline to 2 weeks) Show forest plot

2

152

Mean Difference (IV, Random, 95% CI)

‐2.52 [‐2.86, ‐2.19]

Analysis 1.2

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 2 Paint‐on film versus placebo/no treatment (shade change baseline to 2 weeks).

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 2 Paint‐on film versus placebo/no treatment (shade change baseline to 2 weeks).

2.1 Colgate Simply White 18% CP versus paint‐on placebo

1

77

Mean Difference (IV, Random, 95% CI)

‐2.54 [‐2.89, ‐2.19]

2.2 Colgate Simply White 25% CP versus placebo

1

75

Mean Difference (IV, Random, 95% CI)

‐2.38 [‐3.43, ‐1.33]

3 Whitening strip versus placebo (shade change baseline to 2 weeks) Show forest plot

1

66

Mean Difference (IV, Random, 95% CI)

‐2.83 [‐3.65, ‐2.01]

Analysis 1.3

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 3 Whitening strip versus placebo (shade change baseline to 2 weeks).

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 3 Whitening strip versus placebo (shade change baseline to 2 weeks).

Open in table viewer
Comparison 2. Whitening product versus placebo/no treatment ‐ Colorimetric

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Gel in tray versus placebo (change in compounded colour baseline to 2 weeks) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 2.1

Comparison 2 Whitening product versus placebo/no treatment ‐ Colorimetric, Outcome 1 Gel in tray versus placebo (change in compounded colour baseline to 2 weeks).

Comparison 2 Whitening product versus placebo/no treatment ‐ Colorimetric, Outcome 1 Gel in tray versus placebo (change in compounded colour baseline to 2 weeks).

1.1 Colgate Platinum versus placebo

1

46

Mean Difference (IV, Random, 95% CI)

3.61 [2.45, 4.77]

1.2 Rembrandt versus placebo

1

46

Mean Difference (IV, Random, 95% CI)

2.01 [1.25, 2.77]

2 Whitening strip versus placebo (change in compounded colour baseline to 2 weeks) Show forest plot

1

52

Mean Difference (IV, Random, 95% CI)

2.1 [1.71, 2.49]

Analysis 2.2

Comparison 2 Whitening product versus placebo/no treatment ‐ Colorimetric, Outcome 2 Whitening strip versus placebo (change in compounded colour baseline to 2 weeks).

Comparison 2 Whitening product versus placebo/no treatment ‐ Colorimetric, Outcome 2 Whitening strip versus placebo (change in compounded colour baseline to 2 weeks).

Open in table viewer
Comparison 3. Whitening product versus whitening product ‐ Vita Shade

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Paint‐on gel versus paint‐on gel (change in shade baseline to 2 weeks) Show forest plot

3

Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 3.1

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 1 Paint‐on gel versus paint‐on gel (change in shade baseline to 2 weeks).

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 1 Paint‐on gel versus paint‐on gel (change in shade baseline to 2 weeks).

1.1 Colgate Simply White 18% CP versus 16.4% CP

1

93

Mean Difference (IV, Random, 95% CI)

‐0.40 [‐1.42, 0.62]

1.2 Colgate Simply White 18% CP 3 times a day versus twice daily

1

70

Mean Difference (IV, Random, 95% CI)

‐0.97 [‐1.67, ‐0.27]

1.3 Colgate Simply White 25% CP versus Colgate Simply White 8.7% HP

1

59

Mean Difference (IV, Random, 95% CI)

‐0.32 [‐0.83, 0.19]

2 Strip versus paint‐on gel (change in shade baseline to 2 weeks) Show forest plot

1

59

Mean Difference (IV, Random, 95% CI)

‐1.47 [‐2.50, ‐0.44]

Analysis 3.2

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 2 Strip versus paint‐on gel (change in shade baseline to 2 weeks).

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 2 Strip versus paint‐on gel (change in shade baseline to 2 weeks).

3 Strip versus gel in tray (change in shade baseline to 2 weeks) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 3.3

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 3 Strip versus gel in tray (change in shade baseline to 2 weeks).

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 3 Strip versus gel in tray (change in shade baseline to 2 weeks).

3.1 Crest Strip versus Day White gel in tray

1

56

Mean Difference (IV, Random, 95% CI)

0.66 [‐0.56, 1.88]

3.2 Crest Strip versus Nite White gel in tray

1

56

Mean Difference (IV, Random, 95% CI)

2.39 [1.26, 3.52]

4 Tray application versus tray application (shade comparison baseline and 2 weeks) Show forest plot

3

Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 3.4

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 4 Tray application versus tray application (shade comparison baseline and 2 weeks).

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 4 Tray application versus tray application (shade comparison baseline and 2 weeks).

4.1 10% CP versus 15% CP

1

52

Mean Difference (IV, Random, 95% CI)

‐1.73 [‐3.20, ‐0.26]

4.2 7.5% HP versus 16% CP

1

54

Mean Difference (IV, Random, 95% CI)

‐1.81 [‐2.79, ‐0.83]

4.3 7.5% HP versus 20% CP

1

48

Mean Difference (IV, Random, 95% CI)

0.09 [‐1.36, 1.54]

Open in table viewer
Comparison 4. Whitening product versus whitening product ‐ Colorimetric

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Paint‐on gel versus custom tray (change in compounded colour baseline to 2 weeks) Show forest plot

1

28

Mean Difference (IV, Random, 95% CI)

1.25 [0.41, 2.09]

Analysis 4.1

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 1 Paint‐on gel versus custom tray (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 1 Paint‐on gel versus custom tray (change in compounded colour baseline to 2 weeks).

2 Paint‐on gel versus paint‐on gel (change in compounded colour baseline to 2 weeks) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 4.2

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 2 Paint‐on gel versus paint‐on gel (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 2 Paint‐on gel versus paint‐on gel (change in compounded colour baseline to 2 weeks).

2.1 Crest Night Effects (19% SP ˜ equiv. 5.3% HP) versus Colgate Simply White Night (8.7% HP)

1

56

Mean Difference (IV, Random, 95% CI)

‐0.64 [‐0.90, ‐0.38]

3 Strip (6% HP) versus paint‐on gel (18% CP) (change in compounded colour baseline to 2 weeks) Show forest plot

1

59

Mean Difference (IV, Random, 95% CI)

‐1.87 [‐2.53, ‐1.21]

Analysis 4.3

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 3 Strip (6% HP) versus paint‐on gel (18% CP) (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 3 Strip (6% HP) versus paint‐on gel (18% CP) (change in compounded colour baseline to 2 weeks).

4 Strip versus strip (change in compounded colour baseline to 2 weeks) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 4.4

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 4 Strip versus strip (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 4 Strip versus strip (change in compounded colour baseline to 2 weeks).

4.1 Crest Whitestrips 14% HP versus 6% HP

1

37

Mean Difference (IV, Random, 95% CI)

‐1.70 [‐2.74, ‐0.66]

5 Strip versus gel in tray (change in compounded colour baseline to 2 weeks) Show forest plot

6

Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 4.5

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 5 Strip versus gel in tray (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 5 Strip versus gel in tray (change in compounded colour baseline to 2 weeks).

5.1 Crest Whitestrips HP versus Opalescence 10% CP

5

178

Mean Difference (IV, Random, 95% CI)

‐1.82 [‐3.38, ‐0.26]

5.2 Crest Whitestrips HP versus 15/16% CP

2

73

Mean Difference (IV, Random, 95% CI)

1.31 [‐1.22, 3.85]

5.3 Crest Whitestrips 5.3% HP versus Opalescence 20%

1

14

Mean Difference (IV, Random, 95% CI)

1.55 [0.66, 2.44]

6 Gel in tray versus gel in tray (change in compounded colour baseline to 2 weeks) Show forest plot

8

Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 4.6

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 6 Gel in tray versus gel in tray (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 6 Gel in tray versus gel in tray (change in compounded colour baseline to 2 weeks).

6.1 Opalescence 10% CP versus Opalescence 15% CP

1

18

Mean Difference (IV, Random, 95% CI)

‐0.06 [‐0.92, 0.80]

6.2 Opalescence 10% CP versus Opalescence 20% CP

1

13

Mean Difference (IV, Random, 95% CI)

1.42 [0.45, 2.39]

6.3 Opalescence 15% CP versus Opalescence 20% CP

1

15

Mean Difference (IV, Random, 95% CI)

1.48 [0.58, 2.38]

6.4 Colgate Platinum 10% CP versus Rembrandt Gel + 10% CP

3

136

Mean Difference (IV, Random, 95% CI)

‐1.86 [‐2.70, ‐1.01]

6.5 Day White 7.5% HP versus Nite White Excel 16% CP

1

52

Mean Difference (IV, Random, 95% CI)

2.97 [1.55, 4.39]

6.6 10% CP versus 15% CP assessed 4 weeks post‐treatment

1

25

Mean Difference (IV, Random, 95% CI)

0.03 [‐0.24, 0.30]

6.7 Opalescence 20% CP versus Day White 7.5% HP

1

50

Mean Difference (IV, Random, 95% CI)

‐1.39 [‐3.06, 0.28]

6.8 Opalescence (F) 15% CP versus Day White 5.5% HP

1

50

Mean Difference (IV, Random, 95% CI)

0.06 [‐1.49, 1.61]

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 1 Gel in tray versus placebo (change in shade baseline to 2 weeks).
Figuras y tablas -
Analysis 1.1

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 1 Gel in tray versus placebo (change in shade baseline to 2 weeks).

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 2 Paint‐on film versus placebo/no treatment (shade change baseline to 2 weeks).
Figuras y tablas -
Analysis 1.2

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 2 Paint‐on film versus placebo/no treatment (shade change baseline to 2 weeks).

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 3 Whitening strip versus placebo (shade change baseline to 2 weeks).
Figuras y tablas -
Analysis 1.3

Comparison 1 Whitening product versus placebo/no treatment ‐ Vita Shade, Outcome 3 Whitening strip versus placebo (shade change baseline to 2 weeks).

Comparison 2 Whitening product versus placebo/no treatment ‐ Colorimetric, Outcome 1 Gel in tray versus placebo (change in compounded colour baseline to 2 weeks).
Figuras y tablas -
Analysis 2.1

Comparison 2 Whitening product versus placebo/no treatment ‐ Colorimetric, Outcome 1 Gel in tray versus placebo (change in compounded colour baseline to 2 weeks).

Comparison 2 Whitening product versus placebo/no treatment ‐ Colorimetric, Outcome 2 Whitening strip versus placebo (change in compounded colour baseline to 2 weeks).
Figuras y tablas -
Analysis 2.2

Comparison 2 Whitening product versus placebo/no treatment ‐ Colorimetric, Outcome 2 Whitening strip versus placebo (change in compounded colour baseline to 2 weeks).

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 1 Paint‐on gel versus paint‐on gel (change in shade baseline to 2 weeks).
Figuras y tablas -
Analysis 3.1

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 1 Paint‐on gel versus paint‐on gel (change in shade baseline to 2 weeks).

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 2 Strip versus paint‐on gel (change in shade baseline to 2 weeks).
Figuras y tablas -
Analysis 3.2

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 2 Strip versus paint‐on gel (change in shade baseline to 2 weeks).

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 3 Strip versus gel in tray (change in shade baseline to 2 weeks).
Figuras y tablas -
Analysis 3.3

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 3 Strip versus gel in tray (change in shade baseline to 2 weeks).

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 4 Tray application versus tray application (shade comparison baseline and 2 weeks).
Figuras y tablas -
Analysis 3.4

Comparison 3 Whitening product versus whitening product ‐ Vita Shade, Outcome 4 Tray application versus tray application (shade comparison baseline and 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 1 Paint‐on gel versus custom tray (change in compounded colour baseline to 2 weeks).
Figuras y tablas -
Analysis 4.1

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 1 Paint‐on gel versus custom tray (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 2 Paint‐on gel versus paint‐on gel (change in compounded colour baseline to 2 weeks).
Figuras y tablas -
Analysis 4.2

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 2 Paint‐on gel versus paint‐on gel (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 3 Strip (6% HP) versus paint‐on gel (18% CP) (change in compounded colour baseline to 2 weeks).
Figuras y tablas -
Analysis 4.3

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 3 Strip (6% HP) versus paint‐on gel (18% CP) (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 4 Strip versus strip (change in compounded colour baseline to 2 weeks).
Figuras y tablas -
Analysis 4.4

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 4 Strip versus strip (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 5 Strip versus gel in tray (change in compounded colour baseline to 2 weeks).
Figuras y tablas -
Analysis 4.5

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 5 Strip versus gel in tray (change in compounded colour baseline to 2 weeks).

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 6 Gel in tray versus gel in tray (change in compounded colour baseline to 2 weeks).
Figuras y tablas -
Analysis 4.6

Comparison 4 Whitening product versus whitening product ‐ Colorimetric, Outcome 6 Gel in tray versus gel in tray (change in compounded colour baseline to 2 weeks).

Table 1. Measurement methods and selection of subjects in the Chroma Meter studies

Study

Measurement method

Inclusion/exclusion

Cronin 2005

The CIE L*a*b* System used in digital colour analysis expresses 3 referenced colour co‐ordinate values: L, a, and b. L indicates lightness or brightness, and the co‐ordinates a and b indicate varying amounts of red/green and yellow/blue, respectively. Quantifying colour through the use of devices with this digital technology is possible. More importantly, it offers an objective way of determining the differences in tooth colour and studying the effects of whitening agents.

Exclusion criteria: subjects with anterior restorations covering more than 25% of the facial surfaces of the maxillary anterior teeth, orthodontics, previously bleached teeth within the last 6 months.

Gerlach 2003

Digital images of the facial surfaces of the 6 maxillary anterior teeth were collected at baseline and day 15.

Inclusion criteria: healthy adult with 4 maxillary anterior teeth with shade of "A2" or darker. Exclusion criteria: prior bleaching, current tooth sensitivity, or extensive restorative dentistry or orthodontics appliances involving the facial surfaces of the maxillary anterior teeth.

Gerlach 2002b

Digital image analysis: evaluation of teeth whiteness was carried out using Chroma Meter (Shade Eye‐EX) (Shofu Dental Corp, Menlo Park, CA 94025). Delta
L*, Delta a*, Delta b* represent standard colour space as whiteness/brightness from dark‐to‐light, green‐to‐red, and blue‐to‐yellow respectively.
Participants were positioned in a chin rest and aligned with the aid of a video image. Standardized intra‐oral lighting was achieved.
Values were determined for each pixel with reference to a calibration standard, and these values were averaged across all 6 maxillary anterior teeth.
Whitening benefit was defined as tooth colour change from baseline assessed by the digital imaging measurements Delta b* yellow‐blue, Delta L* light‐dark, and Delta a* is red‐green.
Negative Delta b* (reduction in yellow), and positive Delta L* (increased brightness) were considered to be indicative of a whitening benefit.

Inclusion criteria: healthy adults who desired to have their teeth whitened.
Excluded criteria: history of previously bleached teeth, current tooth sensitivity, or presence facial anterior restorations.

Karpinia 2002

Digital image analysis: to measure teeth whiteness this study used Chroma Meter (Shade Eye‐EX) (Shofu Dental Corp, Menlo Park, CA 94025).
Participants were positioned in a chin rest and aligned with the aid of a video image. Standardized intra‐oral lighting was achieved.
Values from all 12 anterior teeth were averaged to determine overall red green‐blue value for each visit. These values were translated into Delta L*, Delta a*, and Delta b*.

Inclusion criteria: healthy adults with at least 4 maxillary anterior teeth with a tooth shade of A2 or darker as measured using a 16‐tab shade guide.
Exclusion criteria: oral conditions requiring emergency treatment, tooth sensitivity, or a history of previous vital bleaching.

Gerlach 2002a

Digital image analysis (Sh‐HC1000 CCD).
Participants were positioned in a chin rest and aligned with the aid of a video image. Standardized intra‐oral lighting was achieved.
Values from 6 anterior maxillary teeth were averaged to determine overall red green‐blue value for each visit. These values were translated into Delta L*, Delta a*, Delta b*.
Whitening benefit was defined as tooth colour change from baseline assessed by the digital imaging measurements Delta b* yellow‐blue, Delta L* light‐dark, and Delta a* is red‐green.

Inclusion criteria: adults 18 years or older with no prior bleaching history, no tooth sensitivity, no restoration on facial of anterior teeth, no prophylactic for at least 3 months.

Gerlach 2000

Digital image analysis.
The system used in this study was described as "high resolution digital camera (Fuji HC 1000 CCD) with motorized lens connected to a computer".
Participants were positioned in a chin rest and aligned with the aid of a video image. Standardized intra‐oral lighting was achieved.
Values from all 12 anterior teeth were averaged to determine overall red green‐blue value for each visit.
The values were translated into Delta L* a* b*.

Exclusion criteria: sensitive teeth, past tooth whitening, or restorations involving anterior teeth.
Inclusion criteria: healthy adult volunteers.

Gerlach 2001

Digital image analysis.
The system used in this study was described as "high resolution digital camera (Fuji HC 1000 CCD) with motorized lens connected to a computer".
Participants were positioned in a chin rest and aligned with the aid of a video image. Standardized intra‐oral lighting was achieved.
All 6 anterior teeth were measured twice and the scores each colour co‐ordinate and tooth were averaged.

Subjects were assigned after balancing for tooth colour, coffee or tea drinking, and tobacco use, and demographics.
Exclusion criteria: sensitive teeth, past tooth whitening, or restorations involving anterior teeth.
Inclusion criteria: healthy adults.

Kowitz 1994a

Reflectance Spectroscopy: baseline colour measurements were taken on the mid‐facial aspects to each upper central incisor with a small area colorimeter using a custom fabricated silicone jigs to ensure repeatable positioning of the meter. Each reading was repeated 3 times to obtain a mean baseline colour before treatment.

Inclusion criteria: healthy subjects with discolouration equal to or darker than A3 on the Vita Shade Guide.
Exclusion criteria: not reported.

Kowitz 1994b

Reflectance Spectroscopy: baseline colour measurements were taken on the mid‐facial aspects to each upper central incisor with a small area colorimeter using a custom fabricated silicone jigs to ensure repeatable positioning of the meter. Each reading was repeated 3 times to obtain a mean baseline colour before treatment start.

Inclusion criteria: healthy subjects with discolouration equal to or darker than A3 on the Vita Shade Guide.
Exclusion criteria: not reported.

Matis 2000

Digital image analysis: Chroma Meter measures L*, a*, b* colour spaces.
Trubyte Bioform colour Ordered Shade Guide.
Measurements from 6 maxillary anterior teeth were used.
Photographs were used to train in colour matching.

Inclusion criteria: all 6 maxillary anterior teeth had to be present. None of the maxillary anterior teeth could have more than 1/6 of the labial surface covered with a restoration, and the location of a restoration could not interfere with colorimeter placement. The patient had to be at least 18 years of age. The patient had to be willing to refrain from use of tobacco products during the study period.
Exclusion criteria: the use of a professionally applied or prescribed tooth whiteners, in‐office bleaching, or mouth‐guard vital bleaching in the past 3 years. Incisors or canines lighter than B54 or darker than B85 on the Trubyte Bioform colour Ordered Shade Guide. Gross pathoses in the oral cavity. Loe & Silness gingival index score greater than 1. Pregnancy or lactation. Teeth discoloured by tetracycline staining.

Mokhlis 1999

Matching with a shade guide, comparing right and left sides of clinical photographs, using colorimeter.
At each visit the colour of the 6 anterior teeth was measured 3 times, and then averaged.
Using colour photographs taken by Kodak Elite II, 100, 35 mm colour slide film, independently evaluators categorized each side of the mouth using 0 = no, 1 = slight, 2 = moderate, 3 = large.
Trubyte Bioform colour Ordered Shade Guide, 1 experienced evaluator.

All subjects had tooth cleaning performed by a hygienist prior to the study.
Exclusion criteria: medical reasons, gingival index greater than 1, pathological lesions, tetracycline stain, previously bleached teeth, use of tobacco, tetracycline stained teeth.
All subjects received $100.
Inclusion criteria: adult subjects must have all 6 maxillary anterior teeth. None of the teeth have more than 1/6 of the labial surface covered with restorations. Subjects should be willing to sign a consent form and are able to return for recall examination and refrain from the use of tobacco.

Panich 2001

Degree of teeth whiteness was measured using Chroma Meter 321. Eichhold positioning system was used to ensure the colorimeter could return to its predetermined position at baseline.
Slides were projected 3x5 feet and scored using the following scale: 0 = no, 1 = slight distinguishable, 2 = moderate or pronounced, 3 = large or dramatic.
Trubyte Bioform colour Ordered Shade Guide 1 shade was added to represent lightest than the lighter shade available.

Inclusion criteria: adult subjects must have all 6 maxillary anterior teeth. None of the teeth have more than 1/6 of the labial surface covered with restorations. Subjects should be willing to sign a consent form and are able to return for recall examination and refrain from the use of tobacco.
Exclusion criteria: history of medical diseases, bleeding tendencies, rheumatic fever, heart pacemaker, prosthetic joint, or heart valve. Use of tobacco during the study.
Gross pathology. Discoloured teeth due to tetracycline staining. Pregnant or lactating women. Incisors lighter than B54. Used whitener before. Gingival index score higher than 1.0.

Nathoo 1994

Reflectance Spectroscopy: Minolta Chroma Meter. All readings were carried out by the same investigator and under colour balanced operatory light to avoid error.

Inclusion criteria: Shade of teeth A3 or darker.
Exclusion criteria: not reported.

Li 2003

Chroma Meter evaluation was carried out using Minolta CR‐221, calibrated according to the manufacturer's instructions. The measurements were taken directly from the facial surfaces of 6 anterior teeth.

Inclusion criteria: subjects were required to have all maxillary anterior teeth present with minimum shade of A3 or darker. Exclusion criteria: subjects wearing orthodontic appliances; subjects with crowned anterior teeth or had periodontal disease, 5 or more carious lesions, pregnant or lactating, previously used tooth whiteners, or had oral pathologies.

Gerlach 2004

Digital image analysis: subjects were positioned in a chin rest, then images of the anterior facial tooth surfaces were captured using a high‐resolution digital camera (Fuji HC1000 CCD, Fuji Photo Film Co., Tokyo, Japan) and motorized zoom lens under standard polarized lighting conditions.

Inclusion criteria: healthy adult volunteers with no history of vital bleaching or dental prophylaxis within the past month. Exclusion criteria: individuals with tooth sensitivity, extensive restorative dentistry involving the anterior dentition, or fixed or orthodontic devices on the maxillary anterior teeth.

Karpinia 2003

Digital image analysis.

Inclusion criteria: healthy adults volunteers who consented to have their teeth whitened, or evidence of tooth sensitivity, previous tooth whitening, or restorative dentistry on the facial surfaces of the anterior teeth. Exclusion criteria: not reported.

Gerlach 2004

Digital image analysis: objective colour measurement using the L* a* b* colour scale of the Commission International del'Eclairage.

Inclusion criteria: healthy adults. Exclusion criteria: not reported.

Figuras y tablas -
Table 1. Measurement methods and selection of subjects in the Chroma Meter studies
Table 2. Measurement methods and selection of subjects in the Vita Shade Guide studies

Study ID

Measurement method

Inclusion/exclusion

Barnes 1998

Vita Shade Guide.

Adults with good general and dental health and with good oral hygiene.

Brunton 2004

Vita Shade Guide with 16 tabs. 1 examiner recorded the shade values of the labial surfaces of the maxillary anterior teeth.

Inclusion criteria: healthy adults with at least maxillary anterior teeth present with a minimum shade of A3 and available for the 6 months of the study. Exclusion criteria: adults with orthodontic appliances, soft tissue pathology, moderate or advanced periodontal disease, 5 or more carious lesions, pregnant or lactating, history of allergy to any whitening products, or restorations of teeth to be scored.

Cronin 2005

Tooth shades of the 4 maxillary incisors was visually graded using the Vita Shade Guide. The assessment was made under standardized lighting conditions immediately after wiping the teeth dry.

Exclusion criteria: subjects with anterior restorations covering more than 25% of the facial surfaces of the maxillary anterior teeth, orthodontics, previously bleached teeth within the last 6 months.

Kihn 2000

Value‐oriented Vita Lumen (Vita Zahnfabrik, Germany).

Healthy adults with at least A3 or darker anterior tooth colour as recorded using Vita Lumin. In good general and dental health.

Kugel 2000

Vita Shade Guide was used to measure whiteness of the 6 maxillary anterior teeth. B1 represented a score of 1, while C4 represented a score of 16. A decrease in Vita Shade Guide score represented an increase in tooth whiteness.

Exclusion criteria: active caries, hypersensitivity, tetracycline stain, fluorosis, and previous bleaching of teeth.

Li 2003

Vita Shade Guide was used to measure whiteness of the 6 maxillary anterior teeth.

Inclusion criteria: subjects were required to have all maxillary anterior teeth present with minimum shade of A3 or darker. Exclusion criteria: subjects wearing orthodontic appliances; subjects with crowned anterior teeth or had periodontal disease, 5 or more carious lesions, pregnant or lactating, previously used tooth whiteners, or had oral pathologies.

Li 2004

Same as Li 2003.

Same as Li 2003.

Mokhlis 1999

Trubyte Bioform Colour Ordered Shade Guide.

All subjects had tooth cleaning performed by a hygienist prior to the study.
Exclusion criteria: medical reasons, gingival index greater than 1, pathological lesions, tetracycline stain, previously bleached teeth, use of tobacco, tetracycline stained teeth.
All subjects received $100.
Inclusion criteria: adult subjects must have all 6 maxillary anterior teeth. None of the teeth have more than 1/6 of the labial surface covered with restorations. Subjects should be willing to sign a consent form and are able to return for recall examination and refrain from the use of tobacco.

Nathoo 2003

Vita Shade Guide with 16 tabs.

Inclusion criteria: subjects with all maxillary anterior teeth; free from large restorations; and with Vita Shade score of A3 or darker. Exclusion: similar to Li 2004.

Nathoo 2002

Same as Nathoo 2003.

Same as Nathoo 2003.

Sielski 2003

Vita Shade Guide.

Inclusion criteria: same as Li 2003.

Figuras y tablas -
Table 2. Measurement methods and selection of subjects in the Vita Shade Guide studies
Table 3. Quality assessment of included studies

Author, year

Masking

Randomisation

Assessor training

Follow up

Degree of bias

Barnes 1998

1. Yes
2. Yes
3. No
Note: 1 Examiner masking (yes, no); 2 = subject masking (yes, no); and 3 = masking of data analysts (yes, no)

Paired lists of names were supplied to the manufacturer, who assigned 1 member to the control group and 1 to treatment group Concealed: yes

Calibrated clinicians

Yes (at least 80% ) (No < 80%)
83%

Moderate

Brunton 2004

1. Yes
2. Yes
3. No

Randomised into 2 groups
Concealed: not reported

Not reported

Yes
96%

High

Cronin 2005

1. Yes
2. No
3. No

Subjects were stratified according to baseline Vitapan Classical shade scores and gender
Concealed: not reported

Training and reliability of the examiner was not reported

Yes
93.3%

High

Gerlach 2004

1. Yes
2. Yes
3. No

Not reported
Concealed: not reported

Training and reliability of the examiner was not reported

Yes
100%

High

Gerlach 2002b

1. Yes
2. No
3. No

Not reported
Concealed: not reported

Training and reliability of the examiner was not reported

Yes
98%

High

Gerlach 2000

1. Yes
2. No
3. No

Protocol: not reported
Concealed: not reported

Not reported

Yes
88%

High

Gerlach 2001

1. Yes
2. No
3. No

Protocol: not reported
Concealed: not reported

Not reported

Yes
85%

High

Gerlach 2002a

1. Yes
2. Yes
3. No

After balancing for baseline colour, subjects were randomised
Concealed: not reported

Not reported

Yes
91% at 2 weeks
86% at 6 months
Yes
91% at 2 weeks
86% at 6 months

High

Gerlach 2004

1. Yes
2. No
3. No

Subjects were randomly assigned Concealed: not reported

Training and reliability of the examiner was not reported

Yes
97%

High

Gerlach 2003

1. Yes
2. Yes
3. No

Protocol: not reported
Concealed: not reported

Training and reliability of the examiner was not reported

Yes
98%

High

Karpinia 2002

1. No
2. Yes
3. No

The study group was randomised in blocks of 4, balancing for initial tooth colour
Concealed: not reported

Not reported

Yes
99%

High

Karpinia 2003

1. No
2. Yes
3. No

Protocol: not reported
Concealed: not reported

Training and reliability of the examiner was not reported

Yes
96%

High

Kihn 2000

1. Yes
2. Yes
3. No

The subjects were randomly assigned by the company
Concealed: yes

Calibrated clinician

Yes
92%

Moderate

Kowitz 1994a

1. Yes
2. Yes
3. No

Protocol: not reported
Concealed: not reported

Not reported
Concealed: not reported

Yes
96%

High

Kowitz 1994b

1. Yes
2. No
3. No

After balancing for baseline colour, subjects were randomised to either group Concealed: not reported

Not reported

Yes
96%

High

Kugel 2000

1. Yes
2. Yes
3. No

Randomised with a block‐randomisations protocol using Vita Shade Guide score at baseline and gender Concealed: not reported

A standardized, trained, and calibrated examiner was used

Yes
94%

High

Li 2003

1. Yes
2. Yes
3. No

Using randomisation scheme generated by computer software and balanced with average Vitapan Classical shade and age
The group assignment was carried out by the project co‐ordinator without the knowledge of the investigators Concealed: yes

Training: not reported
2 examiners evaluated tooth colour independently and reached consensus

Yes
92%

Two examiners evaluated tooth surfaces independently and reached consensus

High

Li 2004

1. Yes
2. Yes
3. No

Subjects were stratified according to baseline Vitapan Classical shade scores and age, and were randomly assigned within each strata to 1 of the 3 groups Concealed: not reported

Trained and experienced examiner

Yes
86.6%

High

Matis 2000

1. Yes
2. Yes
3. No

The subjects were randomised into groups, according to baseline shade, by an assistant not directly involved in the study. Concealed: yes

1 examiner: experienced

Yes
100%

Moderate

Mokhlis 1999

1. Yes
2. Yes
3. No

Randomised according to the baseline shade guide into 2 groups by a study monitor not directly involved in the study. Concealed: yes

Evaluators were calibrated using colour slides, if differences existed consensus was reached using clinical photographs comparisons.
No consensus mentioned for shade guide matching. It was actually carried out by an "experienced examiner"

Yes
96%

Moderate

Nathoo 1994

1. Yes
2. Yes
3. No

Protocol: not reported
Concealed: not reported

Not reported

Yes
95%

High

Nathoo 2003

1. Yes
2. Yes
3. No

Qualifying subjects were stratified according to gender, age, and baseline VITA Shade Guide scores, and were randomly assigned within strata to 1 or 2 of the 2 study treatments. Concealed: not reported

A single, experienced, trained examiner performed all of the clinical examination

Yes
100%

High

Nathoo 2002

1. Yes
2 . Yes
3. No

Qualifying subjects were stratified according to gender, age, and baseline VITA Shade Guide scores, and were randomly assigned within strata to 1 of the study treatment groups. Concealed: not reported

1 experienced and trained examiner performed all clinical examinations

Yes
96%

High

Panich 2001

1. Yes
2. No
3. No

The patients were placed into 2 groups, according to baseline shade B56 or lighter and B77 or darker. A staff person not associated with the study did the assignment. Concealed: yes

2 evaluators calibrated in a previous study

Yes
100%

High

42 days

Sielski 2003

1. Yes
2. No
3. No

Qualifying subjects were stratified according to gender, age, and baseline VITA Shade Guide scores, and were randomly assigned within strata to one of the 2 study treatment groups. Concealed: not reported

1 experienced and trained examiner performed all clinical examinations

Yes
100%

High

Figuras y tablas -
Table 3. Quality assessment of included studies
Table 4. Side effects reported in the included studies

Study ID

Side effects

Barnes 1998

There was no significant difference in average sensitivity between the active whitener group and the placebo group at the end of 2 weeks. There were no significant changes in gingival condition for either groups between baseline and 2 weeks.

Brunton 2004

Gingivitis scores were reduced from 0.91 to 0.44 (statistically significant).
85% of the subjects reported no tooth sensitivity. 13% reported moderate sensitivity, and 12% reported moderate‐severe tooth sensitivity. 15% reported moderate gingival sensitivity.

Cronin 2005

Not reported.

Gerlach 2004

Tooth sensitivity was more common in the experimental group at 42% while the control group had a prevalence of 26%. 11% of subjects in both groups had oral irritation.

Gerlach 2002b

Tooth sensitivity: 20% in the strip group; 10 % in the tray group. Gingival irritation: 30% in strip and 0 % in the tray.

Gerlach 2000

Tooth sensitivity and gingival irritation were mild to moderate in severity and were transient. The higher the concentration of the peroxide the higher was the sensitivity. The 20% CP product caused 60% tooth sensitivity compared to 9% and 10% in the 10% CP and 15% CP groups.

Gerlach 2001

Tooth sensitivity was more common in the strip group while gingival irritation was more common in the tray system.

Gerlach 2002

A total of 4 subjects (13%) of the study population reported tooth sensitivity at some time during the trial. 3 subjects reported gingival irritation.

Gerlach 2004

Oral irritation and tooth sensitivity were the most common adverse events in the study with 30% of the subjects experiencing one or both of these conditions sometimes during treatment.
The tray group had 33% (5 subjects) mild oral irritation and 33% mild tooth sensitivity while 21.4% of the dentifrice group had mild oral irritation. The paint‐on group had 0% observed or reported irritation and sensitivity.

Gerlach 2003

2 subjects reported tooth sensitivity, 1 in each treatment group. 1 subject in the 19% SP reported mild oral irritation. All adverse events were mild in severity, and no subject discontinued treatment because of product related adverse events.

Karpinia 2002

Tooth sensitivity and oral irritation were the most common adverse events reported. Tooth sensitivity was more common in the strip group at 26% compare to 15% in the tray group.

Karpinia 2003

Transient tooth sensitivity and oral irritation were the most common findings. A total of 29 subjects (51%) reported oral irritation or tooth sensitivity and 10 subjects (18%) had treatment related oral irritation. Tooth sensitivity was more common in the strip group, whereas oral irritation was more common in the combination system group. Both were mild in severity.

Kihn 2000

There was a significant difference in tooth sensitivity associated with use of 10% CP versus use of 15% CP (10% = 2.44 and 15% = 4.58). Incidence of tooth sensitivity was equal between the 2 groups.

Kowitz 1994a

No adverse reactions were clinically evident or reported.

Kowitz 1994b

Tooth sensitivity was reported in 1 subject who dropped out of the study.

Kugel 2000

In the placebo group, 1 patient had slight cervical inflammation over 1 tooth. 1 patient developed a minor superficial cervical lesion on 1 tooth and a second patient a swollen papilla between 2 adjacent teeth. Tooth sensitivity was unremarkable in both groups.

Li 2003

No tooth sensitivity was detected in any subject during clinical examination. Tooth sensitivity reported by the subjects ranged from 11.5% to 19.2% for Crest Whitestrips, 25%‐41.4% for Day White, 8%‐24% for Nite White.
Gingival irritation: the highest reported was in the Day White group (40.7%‐62.3%), while Crest Professional Whitestrips (7.7%‐23%). The Nite White group ranged from 0% to 12% gingival irritation. It was mild in nature, although several subjects in the Day White group reported severe gingival irritation.

Li 2004

Tooth sensitivity: 1 subject reported having mild tooth sensitivity.
There was no significant change in gingival irritation. No subjects complained of any treatment hypersensitivity regardless of the regimen used.

Matis 2000

No statistically significant difference between products was found for gingival sensitivity. Although there was a trend toward greater tooth sensitivity with the 15% product, the difference between products was not statistically significant at the 5% level.

Mokhlis 1999

Both products caused tooth sensitivity and gingival sensitivity. There was no difference between the 2 products.

Nathoo 1994

No adverse reactions were clinically evident or reported.

Nathoo 2003

No adverse reaction reported by the subjects or noted by the examiner.

Nathoo 2002

Throughout the study no adverse effects were associated with the use of either of the 2 treatments.

Panich 2001

CP caused more gum sensitivity than HP. CP and HP were equal in causing tooth sensitivity, and statistically not significant.

Sielski 2003

No adverse effects on the oral hard or soft tissue were observed by the examiner or reported by the subjects when questioned.

Figuras y tablas -
Table 4. Side effects reported in the included studies
Comparison 1. Whitening product versus placebo/no treatment ‐ Vita Shade

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Gel in tray versus placebo (change in shade baseline to 2 weeks) Show forest plot

1

50

Mean Difference (IV, Random, 95% CI)

‐6.29 [‐7.82, ‐4.76]

2 Paint‐on film versus placebo/no treatment (shade change baseline to 2 weeks) Show forest plot

2

152

Mean Difference (IV, Random, 95% CI)

‐2.52 [‐2.86, ‐2.19]

2.1 Colgate Simply White 18% CP versus paint‐on placebo

1

77

Mean Difference (IV, Random, 95% CI)

‐2.54 [‐2.89, ‐2.19]

2.2 Colgate Simply White 25% CP versus placebo

1

75

Mean Difference (IV, Random, 95% CI)

‐2.38 [‐3.43, ‐1.33]

3 Whitening strip versus placebo (shade change baseline to 2 weeks) Show forest plot

1

66

Mean Difference (IV, Random, 95% CI)

‐2.83 [‐3.65, ‐2.01]

Figuras y tablas -
Comparison 1. Whitening product versus placebo/no treatment ‐ Vita Shade
Comparison 2. Whitening product versus placebo/no treatment ‐ Colorimetric

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Gel in tray versus placebo (change in compounded colour baseline to 2 weeks) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

1.1 Colgate Platinum versus placebo

1

46

Mean Difference (IV, Random, 95% CI)

3.61 [2.45, 4.77]

1.2 Rembrandt versus placebo

1

46

Mean Difference (IV, Random, 95% CI)

2.01 [1.25, 2.77]

2 Whitening strip versus placebo (change in compounded colour baseline to 2 weeks) Show forest plot

1

52

Mean Difference (IV, Random, 95% CI)

2.1 [1.71, 2.49]

Figuras y tablas -
Comparison 2. Whitening product versus placebo/no treatment ‐ Colorimetric
Comparison 3. Whitening product versus whitening product ‐ Vita Shade

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Paint‐on gel versus paint‐on gel (change in shade baseline to 2 weeks) Show forest plot

3

Mean Difference (IV, Random, 95% CI)

Subtotals only

1.1 Colgate Simply White 18% CP versus 16.4% CP

1

93

Mean Difference (IV, Random, 95% CI)

‐0.40 [‐1.42, 0.62]

1.2 Colgate Simply White 18% CP 3 times a day versus twice daily

1

70

Mean Difference (IV, Random, 95% CI)

‐0.97 [‐1.67, ‐0.27]

1.3 Colgate Simply White 25% CP versus Colgate Simply White 8.7% HP

1

59

Mean Difference (IV, Random, 95% CI)

‐0.32 [‐0.83, 0.19]

2 Strip versus paint‐on gel (change in shade baseline to 2 weeks) Show forest plot

1

59

Mean Difference (IV, Random, 95% CI)

‐1.47 [‐2.50, ‐0.44]

3 Strip versus gel in tray (change in shade baseline to 2 weeks) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

3.1 Crest Strip versus Day White gel in tray

1

56

Mean Difference (IV, Random, 95% CI)

0.66 [‐0.56, 1.88]

3.2 Crest Strip versus Nite White gel in tray

1

56

Mean Difference (IV, Random, 95% CI)

2.39 [1.26, 3.52]

4 Tray application versus tray application (shade comparison baseline and 2 weeks) Show forest plot

3

Mean Difference (IV, Random, 95% CI)

Subtotals only

4.1 10% CP versus 15% CP

1

52

Mean Difference (IV, Random, 95% CI)

‐1.73 [‐3.20, ‐0.26]

4.2 7.5% HP versus 16% CP

1

54

Mean Difference (IV, Random, 95% CI)

‐1.81 [‐2.79, ‐0.83]

4.3 7.5% HP versus 20% CP

1

48

Mean Difference (IV, Random, 95% CI)

0.09 [‐1.36, 1.54]

Figuras y tablas -
Comparison 3. Whitening product versus whitening product ‐ Vita Shade
Comparison 4. Whitening product versus whitening product ‐ Colorimetric

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Paint‐on gel versus custom tray (change in compounded colour baseline to 2 weeks) Show forest plot

1

28

Mean Difference (IV, Random, 95% CI)

1.25 [0.41, 2.09]

2 Paint‐on gel versus paint‐on gel (change in compounded colour baseline to 2 weeks) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

2.1 Crest Night Effects (19% SP ˜ equiv. 5.3% HP) versus Colgate Simply White Night (8.7% HP)

1

56

Mean Difference (IV, Random, 95% CI)

‐0.64 [‐0.90, ‐0.38]

3 Strip (6% HP) versus paint‐on gel (18% CP) (change in compounded colour baseline to 2 weeks) Show forest plot

1

59

Mean Difference (IV, Random, 95% CI)

‐1.87 [‐2.53, ‐1.21]

4 Strip versus strip (change in compounded colour baseline to 2 weeks) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Subtotals only

4.1 Crest Whitestrips 14% HP versus 6% HP

1

37

Mean Difference (IV, Random, 95% CI)

‐1.70 [‐2.74, ‐0.66]

5 Strip versus gel in tray (change in compounded colour baseline to 2 weeks) Show forest plot

6

Mean Difference (IV, Random, 95% CI)

Subtotals only

5.1 Crest Whitestrips HP versus Opalescence 10% CP

5

178

Mean Difference (IV, Random, 95% CI)

‐1.82 [‐3.38, ‐0.26]

5.2 Crest Whitestrips HP versus 15/16% CP

2

73

Mean Difference (IV, Random, 95% CI)

1.31 [‐1.22, 3.85]

5.3 Crest Whitestrips 5.3% HP versus Opalescence 20%

1

14

Mean Difference (IV, Random, 95% CI)

1.55 [0.66, 2.44]

6 Gel in tray versus gel in tray (change in compounded colour baseline to 2 weeks) Show forest plot

8

Mean Difference (IV, Random, 95% CI)

Subtotals only

6.1 Opalescence 10% CP versus Opalescence 15% CP

1

18

Mean Difference (IV, Random, 95% CI)

‐0.06 [‐0.92, 0.80]

6.2 Opalescence 10% CP versus Opalescence 20% CP

1

13

Mean Difference (IV, Random, 95% CI)

1.42 [0.45, 2.39]

6.3 Opalescence 15% CP versus Opalescence 20% CP

1

15

Mean Difference (IV, Random, 95% CI)

1.48 [0.58, 2.38]

6.4 Colgate Platinum 10% CP versus Rembrandt Gel + 10% CP

3

136

Mean Difference (IV, Random, 95% CI)

‐1.86 [‐2.70, ‐1.01]

6.5 Day White 7.5% HP versus Nite White Excel 16% CP

1

52

Mean Difference (IV, Random, 95% CI)

2.97 [1.55, 4.39]

6.6 10% CP versus 15% CP assessed 4 weeks post‐treatment

1

25

Mean Difference (IV, Random, 95% CI)

0.03 [‐0.24, 0.30]

6.7 Opalescence 20% CP versus Day White 7.5% HP

1

50

Mean Difference (IV, Random, 95% CI)

‐1.39 [‐3.06, 0.28]

6.8 Opalescence (F) 15% CP versus Day White 5.5% HP

1

50

Mean Difference (IV, Random, 95% CI)

0.06 [‐1.49, 1.61]

Figuras y tablas -
Comparison 4. Whitening product versus whitening product ‐ Colorimetric